Bevacizumab in combination with capecitabine for the first-line treatment of metastatic breast cancer: appendix A - RRP decision paper - August 2015
|
Bevacizumab in combination with capecitabine for the first-line treatment of metastatic breast cancer: appendix A - RRP decision paper - August 2015
13 August 2015 (67.63 Kb 19 sec) |
This page was last updated: 10 August 2015